News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–8
Matches
8
Sources here
4
Companies here
2
Search results Stored financial headlines

Active search

8 matching headlines

Ticker or company: PROKMain company stories
Clear
Latest

Stock Titan Deals and strategy

Morgan Stanley (PROK) filings show ProKidney stake at 4.7% and below 5% level

Morgan Stanley and its affiliate, Morgan Stanley Investment Management Inc., have reported their current beneficial ownership in ProKidney Corp. Class A common stock through a Schedule 13G/A amendment. Both entities now hold a 4.7% stake, individually owning approximately 9.65 million and 9.64 million shares respectively, all through shared voting and dispositive power. Crucially, both Morgan Stanley entities have …

Main company 🇺🇸 United States
Read at Stock Titan
Sharemaestro market context Price below Trend Line 52 weeks -44.8% PROK stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates

ProKidney Corp. (PROK) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

PROK main company PROK main company
Sharemaestro market context Price below Trend Line 52 weeks -44.5% · Next-week setup negative 26.2% PROK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights

ProKidney Completed enrollment of patients contributing to the Phase 3 PROACT 1 accelerated approval efficacy analysis, positioning the Company for anticipated pivotal eGFR slope topline results in Q2 2027 On track for completion of full enrollment for PROACT 1 in the second half of …

PROK main company PROK main company
Sharemaestro market context Price below Trend Line 52 weeks -44.5% · Next-week setup negative 26.2% PROK stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

ProKidney Corp. (PROK) director converts paired units into Class A stock

ProKidney Corp. director Brian J.G. Pereira converted 757,164 paired Class B common stock and ProKidney Holdings, LLC common units into an equal number of Class A common shares on August 4, 2026. These transactions, which included both directly held and trust-held securities, were reported …

PROK main company
Sharemaestro market context Price below Trend Line 52 weeks -44.8% PROK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context